AzTrials
AzTrials

Internet AddictionNCT06388655

The Effect of the Mobile EEG-Neurofeedback in Healthy Child and Adolescent

A study testing mobile neurofeedback in people with Internet Addiction, run by Daegu Catholic University Medical Center at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this study was to ascertain the therapeutic impact of mobile neurofeedback (MNF) in neurotypical children when compared to sham MNF. Clinical assessments were conducted both before and after the MNF intervention, and the effectiveness of the intervention was to be validated through these evaluations. Read more about this study

Who is it for?
Ages 8 to 15 yearsHealthy volunteers can take part
Conditions the study is for
Internet Addiction
What is being tested?
mobile neurofeedback
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
61 participants
Where
1 siteSouth Korea
Study dates
10 Jun 2019to 30 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 15 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Child participants ranging from 8 to 15 years of age, who were recruited from the Department of Psychiatry at Daegu Catholic University Medical Center between 2019 and 2021

Who cannot join

  • History of congenital genetic diseases History of brain damage History of neurological disorders History of psychiatric conditions such as schizophrenia spectrum disorder, autism spectrum disorder, obsessive-compulsive disorder, major depressive disorder, or bipolar disorder Participants with an IQ below 70, as determined by the Korean-Wechsler Intelligence Scale for Children-Fourth Edition (K-WISC-IV)

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Daegu Catholic University Medical Center

    Daegu, Nam-gu, 42471

Other trials in South Korea

About this study

Official title: The Effect of the Mobile EEG-Neurofeedback in Healthy Child and Adolescent Participants: a Randomized Sham-control Study

The objective of this study was to ascertain the therapeutic impact of mobile neurofeedback (MNF) in neurotypical children when compared to sham MNF. Clinical assessments were conducted both before and after the MNF intervention, and the effectiveness of the intervention was to be validated through these evaluations.

Read the detailed description

Neurotypical children aged 10-15 participated in the study. All subjects were assessed using the Kiddie Schedule for Affective Disorders and Schizophrenia Present and Lifetime Version Korean Version (K-SADS-PL-K) and confirmed to have no psychiatric symptoms. The participants were randomly assigned to the MNF active (N=31) or sham control (N=30) groups. The MNF program was administered using a mobile app (equipped with a headset with a 2-channel EEG sensor) for 30 min/day, 3 days/week, for 3 months. All participants and their parents completed self-report scales and participants complete neurocognitive function assessments including the continuous performance test, Stroop, children's color trails test-1 and 2, and intelligence test at baseline and after the 3-month MNF program.

Being tested
mobile neurofeedback, sham mobile neurofeedback
Keywords
mobile neurofeedback, neurotypical, internet addiction
Medical subject headings
Internet Addiction Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • mobile neurofeedbackDevice

    The participants were randomly assigned to the MNF active (N=31) or sham control (N=30) groups. The MNF program was administered using a mobile app (equipped with a headset with a 2-channel EEG sensor) for 30 min/day, 3 days/week, for 3 months.

  • sham mobile neurofeedbackDevice

    The sham neurofeedback was implemented through presenting randomized game outcomes, independent of real measurements. The scoring distribution was meticulously adjusted to achieve a realistic spectrum of results, prioritizing median scores to uphold uniformity in user experience.

Study groups in NCT06388655
Study groupRoleWhat they receive
MNF active groupExperimentalIn this study, neurofeedback headsets developed by OmniCNS were utilized, employing a dry EEG method to measure EEG signals at a rate of 250Hz. Signals were then transformed into the frequency domain through Fourier transform, allowing assessment of power across a wide range of frequencies. Feedback activities, like levitation or running, were based on attention levels determined by the Low beta + Middle beta / Theta Power ratio. Participants received training and engaged in neurofeedback games through the Omnifit Brain app using the provided headsets and personal smartphones for 12 weeks, three times a week for 10-20 minutes per session. Four game types based on the theta/beta ratio were offered, allowing participants to choose freely.
Receives: Device: mobile neurofeedback
sham control groupSham comparatorThe sham neurofeedback was implemented through presenting randomized game outcomes, independent of real measurements. The scoring distribution was meticulously adjusted to achieve a realistic spectrum of results, prioritizing median scores to uphold uniformity in user experience.
Receives: Device: sham mobile neurofeedback

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparisons of the means of children's self-scale variables

    Participants' condition regarding internet addiction, among other factors, was assessed using children's self-scales such as the Korea Internet Addiction Scale (K-scale).

    Measured: through study completion, an average of 1 year

Secondary outcomes (6)
  1. Comparisons of the means of parents' self-scale variables : Beck Depression Inventory-II (BDI-II)

    The evaluation of participants was conducted using parents' self-scales : Beck Depression Inventory-II (BDI-II)

    Measured: through study completion, an average of 1 year

  2. Comparisons of the means of parents' self-scale variables : Beck Anxiety Inventory (BAI)

    The evaluation of participants was conducted using parents' self-scales : Beck Anxiety Inventory (BAI)

    Measured: through study completion, an average of 1 year

  3. Comparisons of the means of children's K-WISC-IV(Korean Wechsler Intelligence Scale for Children-IV)

    Participants' intelligence levels were assessed using measures

    Measured: through study completion, an average of 1 year

  4. Comparisons of the means of children's Stroop

    Participants' attention levels were assessed using measures

    Measured: through study completion, an average of 1 year

  5. Comparisons of the means of children's ATA(Advanced Test of Attention)

    Participants' attention levels were assessed using measures

    Measured: through study completion, an average of 1 year

  6. Comparisons of the means of children's CCTT(Children's Color Trails Test)

    Participants' attention levels were assessed using measures

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2024
  2. Study start10 Jun 2019
  3. Primary completion30 Jun 2022
  4. Study completion30 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
61 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06388655
Sponsor's protocol ID
MDCR-19-007
Status last verified
Apr 2024
First submitted
15 Apr 2024
Last updated
29 Apr 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing mobile neurofeedback in people with Internet Addiction, run by Daegu Catholic University Medical Center at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparisons of the means of children's self-scale variables (time frame: through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in